Suspended

Tucatinib Application for HER2+ Metastatic Breast Cancer

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Data Collection

Who is eligible

Brain Diseases+9

+ Brain Neoplasms

+ Breast Diseases

See all eligibility criteria
How is it accessible

Suspended

Available upon a request by a licensed MD
Expanded Access
See protocol details

Summary

Principal SponsorSeagen Inc.
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

This study focuses on the use of a drug called Tucatinib for individuals diagnosed with HER2+ Metastatic Breast Cancer. HER2+ is a type of breast cancer that tests positive for a protein called human epidermal growth factor receptor 2 (HER2). The study aims to provide access to Tucatinib for patients who are not part of other clinical trials. The importance of this study lies in its potential to offer a new treatment option for patients with this specific type of breast cancer.

Official TitleExpanded Access Use of Tucatinib for HER2+ Metastatic Breast Cancer
NCT03424473
Principal SponsorSeagen Inc.
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Conditions

Pathology

Brain DiseasesBrain NeoplasmsBreast DiseasesBreast NeoplasmsCentral Nervous System DiseasesNeoplasmsNeoplasms by SiteNervous System DiseasesNervous System NeoplasmsSkin DiseasesCentral Nervous System NeoplasmsSkin and Connective Tissue Diseases

Criteria

Inclusion Criteria: \- Exclusion Criteria: \-

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.
This study has no location dataSave this study to your profile to know when the location data is available.
SuspendedNo study centers